Product Information

CEPHALEXIN 250 MG/5 ML SUSP is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0750 per ML under NDC 67877054588. Its NADAC has been published 368 times since Aug 7, 2019.

FDA first approved this application on Mar 26, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Cephalexin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for CEPHALEXIN 250 MG/5 ML SUSP has been published 368 times since Aug 7, 2019, and over the history we have for it it has declined 34.7%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.